Doctors track Real-Life results of kidney drug in eastern europe

NCT ID NCT06203704

Summary

This study observed how doctors use the medication dapagliflozin to treat chronic kidney disease in everyday practice. It followed over 1,000 patients across seven Eastern European countries for up to a year after they started the drug. The goal was to understand which patients receive this treatment and what happens to their kidney health and hospital visits in real-world settings, not a controlled clinical trial.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE(CKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Plovdiv, Bulgaria

  • Research Site

    Sofia, Bulgaria

  • Research Site

    Varna, Bulgaria

  • Research Site

    Zagreb, Croatia

  • Research Site

    Békéscsaba, Hungary

  • Research Site

    Budapest, Hungary

  • Research Site

    Debrecen, Hungary

  • Research Site

    Gödöllő, Hungary

  • Research Site

    Karcag, Hungary

  • Research Site

    Kecskemét, Hungary

  • Research Site

    Miskolc, Hungary

  • Research Site

    Nagykanizsa, Hungary

  • Research Site

    Nyíregyháza, Hungary

  • Research Site

    Pécs, Hungary

  • Research Site

    Siófok, Hungary

  • Research Site

    Szeged, Hungary

  • Research Site

    Szombathely, Hungary

  • Research Site

    Veszprém, Hungary

  • Research Site

    Bialystok, Poland

  • Research Site

    Bolesławiec, Poland

  • Research Site

    Bydgoszcz, Poland

  • Research Site

    Choszczno, Poland

  • Research Site

    Czarnków, Poland

  • Research Site

    Katowice, Poland

  • Research Site

    Krakow, Poland

  • Research Site

    Lodz, Poland

  • Research Site

    Olsztyn, Poland

  • Research Site

    Opole, Poland

  • Research Site

    Sieradz, Poland

  • Research Site

    Szczecin, Poland

  • Research Site

    Środa Wielkopolska, Poland

  • Research Site

    Węgrów, Poland

  • Research Site

    Wroclaw, Poland

  • Research Site

    Zielona Góra, Poland

  • Research Site

    Żywiec, Poland

  • Research Site

    Bistriţa, Romania

  • Research Site

    Bucharest, Romania

  • Research Site

    Cluj-Napoca, Romania

  • Research Site

    Galati, Romania

  • Research Site

    Iași, Romania

  • Research Site

    Oradea, Romania

  • Research Site

    Reşiţa, Romania

  • Research Site

    Satu Mare, Romania

  • Research Site

    Târgu Mureş, Romania

  • Research Site

    Timișoara, Romania

  • Research Site

    Belgrade, Serbia

  • Research Site

    Brežice, Slovenia

  • Research Site

    Cerknica, Slovenia

  • Research Site

    Mengeš, Slovenia

  • Research Site

    Portorož, Slovenia

  • Research Site

    Ptuj, Slovenia

  • Research Site

    Radlje ob Dravi, Slovenia

  • Research Site

    Ruše, Slovenia

  • Research Site

    Sevnica, Slovenia

  • Research Site

    Škofja Loka, Slovenia

  • Research Site

    Zagorje, Slovenia

Conditions

Explore the condition pages connected to this study.